InvestorsHub Logo
Followers 39
Posts 2870
Boards Moderated 0
Alias Born 12/06/2003

Re: DewDiligence post# 3298

Wednesday, 01/28/2015 12:22:39 PM

Wednesday, January 28, 2015 12:22:39 PM

Post# of 108191
So?

Did any misguided soul expect anything else? Has Mr. Feuerstein discovered that uncontrolled trials still have meaning? Is Adam preparing his indepth financial analysis of scientific data?

So many questions, so few answers.

Doesn't anybody here care about man's best friends who can point the way with their lives on the line?

Guess not.

ADXS did blunder in attempting to demonstrate a prophylactic rather than only a therapeutic capability without sufficient preliminaries. Their fired CSO probably deserved his dumping.

Adjuvants for cancer vaccines obviously are allowed more toxicity than prophylactic vaccines, even ones treating a condition signaling HPV infection. I don't think it a given that ADXS cannot treat CIN. Women are far less likely to drop out of trials when efficacy in treating cancer is demonstrated and the vaccine is on the market.

All JMO.

Best, Terry
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News